GlaxoSmithKline reported 8.63B in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Alcon AG ALC:SW 1.97B 115M
AstraZeneca AZN:LN 12.3B 763M
Bayer BAYN:GR 9.1B 154M
Fresenius FRE:GR 8.84B 527M
Fresenius Medical Care FME:GR 4.2B 262M
Genmab GEN:DC 1.61B 205M
Hikma Pharmaceutical HIK:LN 1.08B 209M
Lonza Group LONN:SW 2.33B 108M
Novartis NOVN:VX 10.96B 826M
Orion ORNBV:FH 236.6M 53M
Philips PHIA:NA € 4782M 984M
Recordati REC:IM 262.8M 2.28M